loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 91353 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Granules India Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NAPROXEN SODIUM (1)

    filter

    01 GRANULES INDIA (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 220MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Naproxen Sodium

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET;ORAL
    220MG
    NAPROXEN SODIUM
    USA
    91353
    2011-09-20
    OTC
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 91353

    Looking for CTD TGA MCC DOSSIER APPLICATION 91353 1

    19

    Granules India Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for World-class facilities for APIs, PFIs & FDFs, Serving customers in over 75+ countries.

    One of their notable products is NAPROXEN SODIUM, with a corresponding application number 91353 and regulatory information .

    proudly manufactured in the

    approval since 2011-09-20

    Granules India Limited's NAPROXEN SODIUM TABLET;ORAL, medication with 220MG of NAPROXEN SODIUM.

    Post Enquiry
    POST ENQUIRY